Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Esperion Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 148
- +12 vs. Q2 2022
- Shares held
- 63.3M
- +8.00M (+14.5%) vs. Q2 2022
- Total value
- $425.5M
- +$73.4M (+20.8%) vs. Q2 2022
- New holders
- 22
- 59 more added
- Sold out
- 10
- 41 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 191 | $646.8M |
| Q1 2026 | 207 | $479.3M |
| Q4 2025 | 201 | $559.6M |
| Q3 2025 | 189 | $286.1M |
| Q2 2025 | 164 | $96.6M |
| Q1 2025 | 187 | $171.5M |
| Q4 2024 | 190 | $277.9M |
| Q3 2024 | 184 | $214.3M |
| Q2 2024 | 176 | $304.2M |
| Q1 2024 | 152 | $336.2M |
| Q4 2023 | 132 | $215.3M |
| Q3 2023 | 123 | $75.9M |
| Q2 2023 | 124 | $103.6M |
| Q1 2023 | 165 | $129.1M |
| Q4 2022 | 164 | $457.6M |
| Q3 2022 | 148 | $425.5M |
| Q2 2022 | 137 | $352.1M |
| Q1 2022 | 132 | $241.2M |
| Q4 2021 | 133 | $268.0M |
| Q3 2021 | 139 | $299.4M |
| Q2 2021 | 142 | $599.4M |
| Q1 2021 | 156 | $805.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 169,826 | $1.14M | 0.00% | +8,011+5.0% | Added |
| Tenor Capital Management Co., L.P. | 185,838 | $1.25M | 0.03% | 00.0% | Unchanged |
| Pinnacle Associates Ltd | 242,616 | $1.63M | 0.04% | −14,618−5.7% | Reduced |
| Pentwater Capital Management LP | 255,092 | $1.71M | 0.03% | −68,610−21.2% | Reduced |
| Monaco Asset Management SAM | 260,000 | $1.74M | 0.78% | +87,500+50.7% | Added |
| Boothbay Fund Management, LLC | 263,058 | $1.76M | 0.06% | −8,485−3.1% | Reduced |
| Bank of New York Mellon Corp | 272,406 | $1.82M | 0.00% | +31,217+12.9% | Added |
| Wellington Management Group LLP | 274,425 | $1.84M | 0.00% | −18,353−6.3% | Reduced |
| Renaissance Technologies LLC | 286,700 | $1.92M | 0.00% | −98,600−25.6% | Reduced |
| Parkman Healthcare Partners LLC | 296,381 | $1.99M | 0.56% | +296,381 | New |
| Nuveen Asset Management, LLC | 301,359 | $2.02M | 0.00% | +106,392+54.6% | Added |
| Silverarc Capital Management, LLC | 314,095 | $2.10M | 0.89% | +314,095 | New |
| Pura Vida Investments, LLC | 332,123 | $2.23M | 0.34% | +120,000+56.6% | Added |
| D. E. Shaw & Co., Inc. | 351,039 | $2.35M | 0.00% | −352,439−50.1% | Reduced |
| Cubist Systematic Strategies, LLC | 361,052 | $2.42M | 0.02% | +105,215+41.1% | Added |
| ExodusPoint Capital Management, LP | 364,951 | $2.44M | 0.03% | +340,944+1,420.2% | Added |
| JPMorgan Chase & Co | 400,836 | $2.69M | 0.00% | −479,687−54.5% | Reduced |
| Highbridge Capital Management LLC | 419,918 | $2.81M | 0.04% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 465,799 | $3.12M | 0.00% | +204,241+78.1% | Added |
| Commodore Capital LP | 467,468 | $3.13M | 0.50% | +467,468 | New |
| Invesco Ltd. | 496,516 | $3.33M | 0.00% | +474,610+2,166.6% | Added |
| Tang Capital Management LLC | 500,000 | $3.35M | 0.41% | +500,000 | New |
| Citadel Advisors LLC | 514,738 | $3.45M | 0.00% | +413,144+406.7% | Added |
| J. Goldman & Co LP | 553,010 | $3.71M | 0.28% | +553,010 | New |
| Marshall Wace, LLP | 560,987 | $3.76M | 0.01% | +534,387+2,009.0% | Added |
| Northern Trust Corp | 582,008 | $3.90M | 0.00% | +14,312+2.5% | Added |
| Altium Capital Management LP | 659,869 | $4.42M | 1.66% | −503,000−43.3% | Reduced |
| Walleye Capital LLC | 698,343 | $4.68M | 0.11% | −26,111−3.6% | Reduced |
| Balyasny Asset Management LLC | 795,671 | $5.33M | 0.02% | +783,700+6,546.7% | Added |
| Schonfeld Strategic Advisors LLC | 803,069 | $5.38M | 0.05% | +743,069+1,238.4% | Added |
| Morgan Stanley | 1,009,781 | $6.77M | 0.00% | +215,070+27.1% | Added |
| Two Sigma Investments, LP | 1,068,438 | $7.16M | 0.02% | +686,035+179.4% | Added |
| Two Sigma Advisers, LP | 1,084,300 | $7.26M | 0.02% | +1,070,900+7,991.8% | Added |
| Rhenman & Partners Asset Management AB | 900,000 | $7.32M | 0.77% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,127,580 | $7.55M | 0.00% | +32,168+2.9% | Added |
| Woodline Partners LP | 1,195,705 | $8.01M | 0.12% | +351,070+41.6% | Added |
| Platinum Investment Management Ltd | 1,430,001 | $9.58M | 0.40% | −193,439−11.9% | Reduced |
| State Street Corp | 1,533,148 | $10.3M | 0.00% | +288,609+23.2% | Added |
| Paradigm Biocapital Advisors LP | 1,719,831 | $11.5M | 1.62% | +311,781+22.1% | Added |
| Millennium Management LLC | 1,723,175 | $11.5M | 0.01% | −983,115−36.3% | Reduced |
| Ikarian Capital, LLC | 2,131,147 | $14.3M | 7.13% | +76,545+3.7% | Added |
| Point72 Asset Management, L.P. | 2,788,300 | $18.7M | 0.08% | +1,725,204+162.3% | Added |
| Vanguard Group Inc | 4,038,525 | $27.1M | 0.00% | −257,673−6.0% | Reduced |
| Bellevue Group AG | 4,225,264 | $28.3M | 0.41% | −10,000−0.2% | Reduced |
| Meditor Group Ltd | 4,468,835 | $29.9M | 19.92% | 00.0% | Unchanged |
| BlackRock Inc. | 4,558,644 | $30.5M | 0.00% | +264,412+6.2% | Added |
| Deep Track Capital, LP | 5,636,587 | $37.8M | 1.87% | −363,413−6.1% | Reduced |
| Wasatch Advisors Inc | 7,463,016 | $50.0M | 0.35% | −82,992−1.1% | Reduced |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −137,744−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −19,768−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −12,300−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,840−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −7,830−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2,312−100.0% | Sold out |
| Ahrens Investment Partners LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| O'Dell Group, LLC | 0 | $0 | 0.00% | −261−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Private Capital Group, LLC | – | – | – | – | Not filed |